[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335390-105":59,"doc-detail-335390-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","herbal-medicines-for-the-improvement-of-immune-function-in-patients-with-non-small-cell-lung-cancer-a-systematic-review-and-meta-analysis","Herbal Medicines for the Improvement of Immune Function in Patients With Non-Small Cell Lung Cancer - A Systematic Review and Meta-Analysis","","Background: Lung cancer carries the highest global mortality, making immune preservation and minimizing treatment-related adverse events increasingly important. This study assessed the immunological effects of herbal medicine (HM) used alone, independent of conventional therapies, in non-small cell lung cancer (NSCLC). Methods: Searches across eight databases covered studies published to March 2023, with bias assessed using RevMan 5.4 and meta-analyses of CD4+ and CD8+ outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/herbal-medicines-for-the-improvement-of-immune-function-in-patients-with-non-small-cell-lung-cancer-a-systematic-review-and-meta-analysis/335390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/herbal-medicines-for-the-improvement-of-immune-function-in-patients-with-non-small-cell-lung-cancer-a-systematic-review-and-meta-analysis/335390.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of this study regarding herbal medicine in NSCLC?","Question",{"text":112,"@type":113},"To investigate the immunological effects of herbal medicine (HM) used alone, without conventional cancer therapies, in patients with non-small cell lung cancer (NSCLC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies selected and outcomes analyzed?",{"text":117,"@type":113},"The review searched eight databases for articles published until March 2023. Bias risk was assessed using RevMan 5.4, and meta-analyses were conducted for CD4+ and CD8+ levels reported in included RCTs.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune markers showed significant changes in the HM-alone group?",{"text":121,"@type":113},"Meta-analyses indicated significant increases in CD4+ and the CD4+/CD8+ ratio, while CD8+ levels decreased compared with control groups. A single trial also reported decreased IL-1, IL-6, TNF-a, and Tregs, alongside increased Th17 and Th17/Treg ratios.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335390,1790149326,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Herbal Medicines for the Improvement of Immune Function in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis  \nIntegrative Cancer Therapies Volume 23: 1–13  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15347354241287775](DOI: 10.1177/15347354241287775)[ ](DOI: 10.1177/15347354241287775)[journals.sagepub.com/home/ict](journals.sagepub.com/home/ict)  \nYoungmin Cho, KMD 1†, Hwa-Seung Yoo, KMD, PhD 1,2†, Soo-Dam Kim, PhD3, Mimi Ko, PhD3, Han-eum Joo, KMD 1, Soobin Jang, KMD, PhD4,  \nand Mi-Kyung Jeong, KMD, PhD3  \nAbstract  \nBackground: Lung cancer has the highest mortality rate of all cancers worldwide. Conserving the immune system and reducing the adverse events associated with cancer treatment have become increasingly important. Our study aimed to investigate the immunological effects of herbal medicine (HM) alone, independent of conventional cancer therapies, in patients with non-small cell lung cancer (NSCLC). Methods: We searched 8 databases for articles published until March 2023. Bias risk was assessed using RevMan 5.4. Meta-analyses of CD4+ and CD8+ levels reported in the included RCTs were also performed. Results: A total of 610 patients from 5 RCTs were included in the analysis. Immune markers in the peripheral blood of patients treated with HM alone were compared with those in the control group. As a result of meta-analyses, CD4+ (three studies; mean difference(MD) = 5.21, 95 confidence interval (CI) [3.26, 7.27], I2 = 61%, n = 428) and CD4+/ CD8+ (two studies; MD = 0.22, 95% CI [0. 18, 0.26], I2 = 0%, n = 278) significantly increased in the treatment group, while CD8+ levels (three studies; MD = −3.04, 95% CI [−5.80, −0.29], I2 = 74%, n = 428) decreased in HM groups compared to comparison groups. In a single trial, IL-1, IL-6, tumor necrosis factor (TNF)-a levels and the number of Tregs in the treatment group significantly decreased, while Th17 levels and the Th17/Treg ratios increased. Conclusion: This study provides a comprehensive and systematic review of the immunological effects of HM in patients with NSCLC. Future studies should explore how the immunological effects of HM correlate with clinical outcomes, such as tumor response and survival rates. PROSPERO registration: CRD42023459  \nKeywords  \nCancer, Lung cancer, Non-small cell lung cancer, Immune function, Herbal medicine Submitted February 19, 2024; revised September 1, 2024; accepted September 13, 2024  \nIntroduction  \nLung cancer is the second most common cancer worldwide 1 and has the highest mortality rate, accounting for 18 584 (22 .3%) of the 83 378 deaths from cancer in Korea in 2022.2 With recent advances in early detection and surgical treatment, the 5-year relative survival rate of patients with localized lung cancer has increased to 62.8%; however, in the case of regional and distant metastases, the survival rate has decreased to 34 . 8% and 8 .2%, respectively.3  \nThe use of immune checkpoint inhibitors (ICIs) has significantly altered the therapeutic landscape for advanced non-small cell lung cancer (NSCLC) by targeting the immune system. However, most lung cancer patients experience either primary or acquired resistance, which can lead  \n1 Daejeon Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea  \n2Seoul Korean Medicine Hospital of Daejeon University, Seoul, Republic of Korea  \n3Korea Institute of Oriental Medicine, Daejeon, Republic of Korea 4Daegu Haany University, Gyeongsan, Republic of Korea  \n†These authors contributed equally to this work as co-first authors.  \nCorresponding Authors:  \nMi-Kyung Jeong, Korea Medicine Convergence Research Division, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.  \n[Email: oiny2000@kiom.re.kr](Email: oiny2000@kiom.re.kr)  \nSoobin Jang, Department of Preventive Medicine, Colleg","cbCais37qxRrVbAh","https://ap.wps.com/l/cbCais37qxRrVbAh","pdf",990520,13,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Keywords\n# Introduction","[{\"question\":\"What was the goal of this study regarding herbal medicine in NSCLC?\",\"answer\":\"To investigate the immunological effects of herbal medicine (HM) used alone, without conventional cancer therapies, in patients with non-small cell lung cancer (NSCLC).\"},{\"question\":\"How were studies selected and outcomes analyzed?\",\"answer\":\"The review searched eight databases for articles published until March 2023. Bias risk was assessed using RevMan 5.4, and meta-analyses were conducted for CD4+ and CD8+ levels reported in included RCTs.\"},{\"question\":\"What immune markers showed significant changes in the HM-alone group?\",\"answer\":\"Meta-analyses indicated significant increases in CD4+ and the CD4+/CD8+ ratio, while CD8+ levels decreased compared with control groups. A single trial also reported decreased IL-1, IL-6, TNF-a, and Tregs, alongside increased Th17 and Th17/Treg ratios.\"}]","Herbal Medicines for the Improvement of Immune Function in Patients With Non-Small Cell Lung Cancer - A Systematic Review and Meta-Analysis | PDF",1790010789,33]